Cite

HARVARD Citation

    Moradi, A. et al. (n.d.). Subject-Relevant Outcomes of On-Label 50 U AbobotulinumtoxinA Treatment for Moderate-to-Severe Glabellar Lines Across Three Individual Trials. Toxicon. pp. S42-. [Online]. 
  
Back to record